Barclays
EXOZ

Barclays’s eXoZymes Inc EXOZ Stock Holding History

Barclays’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$632 Buy
+75
New +$707 ﹤0.01% 4975

Other funds holding EXOZ

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's EXOZ Position: Q2 2026 in Review

Barclays opened a new position in eXoZymes Inc (EXOZ) in Q2 2026: 75 shares worth $632. The stake represents ﹤0.01% of the portfolio and ranks #4975 among its holdings.

10 funds tracked by Wall St. Rank hold EXOZ as of Q2 2026.

  • Barclays held 75 shares of eXoZymes Inc worth $632 as of Q2 2026.
  • eXoZymes Inc was a new Barclays position in Q2 2026.
  • eXoZymes Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4975 holding.
  • 10 funds tracked by Wall St. Rank held eXoZymes Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.